bullish

[Blue Lotus Daily]: XPEV/LI/NIO/1211.HK/BGNE

217 Views14 Nov 2023 10:45
​Auto media company conducts crash test, favoring Huawei over XPeng; new energy vehicle sales growth accelerates in October 2023; Gilead's success in TIGIT in Gastric Cancer means little to BeiGene.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Logo
Top Quartile
Blue Lotus Research Institute
China growth and global non-US Internet equities
Hong KongInformation Technology & Consumer DiscretionaryEquity Bottom-UpThematic (Sector/Industry)
  • [Blue Lotus Daily]: XPEV/LI/NIO/1211.HK/BGNE
    14 Nov 2023
x